Optimizing Oncology Generic Medication Selection in the Gulf Region: Expert Consensus and MCDA Tool Development.

ABSTRACT: Background: Cancer remains a leading global health challenge, with high mortality rates and increasing financial burdens on healthcare systems. In the Gulf Cooperation Council countries, generic oncology medications offer a cost-effective alternative to patented treatments. However, disparities in regulatory frameworks and concerns about quality and supply reliability hinder their widespread adoption. Addressing these challenges is crucial to ensuring optimal access to oncology treatments. Methods: This study employed multicriteria decision analysis to evaluate key factors influencing the selection of off-patent oncology drugs. A structured survey was conducted among 10 formulary management experts from the United Arab Emirates, Qatar, Kuwait, Bahrain, and Oman. Participants

SUBMITTER: Hamad A 

PROVIDER: S-EPMC12276732 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature